使用警語:中文譯文來源為 AI 翻譯,僅供參考,實際內容請以英文原文為主
Operator
Operator
Ladies and gentlemen, thank you for standing by. Welcome to the AMN Healthcare Fourth Quarter 2017 Earnings call. (Operator Instructions)
各位女士、先生,感謝您稍候。歡迎參加 AMN Healthcare 2017 年第四季財報電話會議。(接線員指示)
As a reminder, the conference is being recorded. And I'll now turn the meeting over to our host, Director of Investor Relations, Mr. Randy Reece. Please go ahead, sir.
提醒各位,本次會議將進行錄音。現在我將把會議交給我們的主持人——投資人關係總監 Randy Reece 先生。先生,請開始。
Randle Reece
Randle Reece
Good afternoon, everyone. Welcome to AMN Healthcare's Fourth Quarter and 2017 Earnings Call.
各位下午好。歡迎參加 AMN Healthcare 2017 年第四季及全年財報電話會議。
A replay of this webcast will be available until February 28 at amnhealthcare.investorroom.com following the conclusion of this call. Details for the audio replay of the conference call are in our earnings release issued this afternoon.
本次網路直播的重播將於本次電話會議結束後,於 amnhealthcare.investorroom.com 提供至 2 月 28 日止。本次電話會議音訊重播的相關細節,已載於我們今天下午發布的財報新聞稿中。
Various remarks we make during this call about future expectations, projections, plans, events or circumstances constitute forward-looking statements. These statements reflect the company's current beliefs based upon information currently available to it. Our actual results may differ materially from those indicated by these forward-looking statements as a result of various factors, including those identified in our most recent Form 10-K and subsequent filings with the SEC. The company does not intend to update the guidance or any forward-looking statements provided today prior to its next earnings release.
我們在本次電話會議中就未來預期、預測、計畫、事件或情況所作的各項評論,均構成前瞻性陳述。這些陳述反映公司基於目前可得資訊所持有的現行信念。由於各種因素(包括我們最近一期 Form 10-K 及其後向 SEC 提交之文件中所識別的因素),實際結果可能與這些前瞻性陳述所示存在重大差異。公司無意在下一次財報發布前更新今日提供的指引或任何前瞻性陳述。
This call contains certain non-GAAP financial information. Information regarding and reconciliations of these non-GAAP measures to the most directly comparable GAAP measures are included in our earnings release and on the Financial Reports page of the company's website, which can be accessed at amnhealthcare.investorroom.com.
本次電話會議包含若干非 GAAP 財務資訊。關於這些非 GAAP 指標,以及其與最直接可比之 GAAP 指標的調節資訊,已載於我們的財報新聞稿及公司網站的「財務報告」頁面,可於 amnhealthcare.investorroom.com 查閱。
On the call today are Susan Salka, President and Chief Executive Officer; Brian Scott, Chief Financial Officer; Ralph Henderson, President of Professional Services and Staffing; and Dan White, President of Strategic Workforce Solutions. I will now turn the call over to Susan.
今天出席電話會議的有:總裁兼執行長 Susan Salka;財務長 Brian Scott;專業服務與派遣事業總裁 Ralph Henderson;以及策略性人力解決方案事業總裁 Dan White。現在我把電話交給 Susan。
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Thank you so much, Randy. 2017 was another milestone year for AMN Healthcare and we are very proud to end on a strong note with revenue and profitability ahead of our expectations for the fourth quarter. Through the year, AMN proved that we could respond to short-term surprises while increasing long-term investments. Our strategy to evolve our workforce solutions portfolio and extend our capabilities benefits our clients, our health care providers, team members and our shareholders.
非常感謝你,Randy。2017 年對 AMN Healthcare 而言是另一個里程碑之年,我們也非常自豪能以強勁表現作結,第四季營收與獲利能力均優於我們的預期。回顧全年,AMN 證明我們能在提升長期投資的同時,因應短期的意外變化。我們致力於演進人力解決方案產品組合並延伸能力的策略,讓客戶、醫療照護提供者、團隊成員以及股東皆能受益。
Over the last 5 years, AMN Healthcare has doubled annual revenue and more than tripled adjusted EBITDA and our enterprise value. The addition of higher-margin service lines that expanded value to our clients enabled us to improve our margin profile. Our scalable business model also resulted in improved operating leverage in all of our businesses. 2017 was a year with less than optimal market conditions, and yet, AMN and our industry continued to deliver critical value to the health care community and the patients that they serve.
過去 5 年,AMN Healthcare 的年營收倍增,調整後 EBITDA 與企業價值更成長逾三倍。透過加入更高毛利的服務線並為客戶創造更高價值,我們得以改善利潤結構。我們可擴展的商業模式也使各項業務的營運槓桿提升。2017 年市場條件並非最佳,但 AMN 與我們的產業仍持續為醫療社群及其服務的病患提供關鍵價值。
For the full year, AMN grew revenue 5% to nearly $2 billion, despite a 2% headwind from minimal labor disruption business. This was led by 8% growth in our largest business of travel nursing. Consolidated adjusted EBITDA grew 8% and reached a margin of 12.9%, improving by 40 basis points year-over-year.
就全年而言,儘管最低限度勞動中斷業務帶來 2% 的逆風,AMN 營收仍成長 5% 至接近 20 億美元。成長主要由我們最大業務——旅遊護理(travel nursing)——的 8% 成長所帶動。合併調整後 EBITDA 成長 8%,並達到 12.9% 的利潤率,年增 40 個基點。
The lead story for AMN last year was our success in MSP. In 2017, we won new MSP clients with over $230 million in gross spend under management. We are on a solid path for 2018, starting the year with a robust MSP sales pipeline.
去年 AMN 最重要的亮點,是我們在 MSP 的成功。2017 年,我們贏得新的 MSP 客戶,管理下的總支出(gross spend under management)超過 2.3 億美元。我們正穩健邁向 2018 年,並以強勁的 MSP 銷售管線展開新的一年。
We had a strong fourth quarter with revenue and adjusted EBITDA beating the upper end of our guidance. Our revenue of $509 million was 4% higher year-over-year, led by strength in Travel Nurse and Allied. The quarter also included 4% year-over-year revenue growth for our Locum Tenens segment. Our adjusted EBITDA was $64 million and represented a margin of 12.6%. The overall demand environment remains favorable and macro drivers support continued growth in our business.
我們第四季表現強勁,營收與調整後 EBITDA 均超越指引區間上緣。營收 5.09 億美元,年增 4%,主要由旅遊護理與 Allied 的強勁表現帶動。本季亦包含我們 Locum Tenens 部門 4% 的年增營收。調整後 EBITDA 為 6,400 萬美元,利潤率為 12.6%。整體需求環境仍然有利,總體驅動因素也支持我們業務持續成長。
We work daily to evolve our business model to stay ahead of clients' needs and the competition. We are investing back into the business to fuel future growth, to retain and recruit the best talent and to build on our competitive advantages. Innovation and investment are essential to the future of AMN and to achieving our goal of a 14% adjusted EBITDA margin by 2020.
我們每天都在推動商業模式演進,以領先客戶需求與競爭對手。我們將資金再投入業務,以驅動未來成長、留任並招募最佳人才,並鞏固我們的競爭優勢。創新與投資對 AMN 的未來至關重要,也有助於達成我們在 2020 年前將調整後 EBITDA 利潤率提升至 14% 的目標。
Now let's review fourth quarter performance and trends for our business. Our Nurse and Allied segment posted revenue of $321 million, higher by 4% year-over-year. Revenue for our largest business, travel nurse staffing, increased 8% year-over-year. This growth was driven primarily by volume increases. Our investments in digital marketing and recruitment of new candidates also are paying off with applicants and new traveler starts up year-over-year. In recent months, the demand environment for travel nurse staffing showed improving momentum. Although overall demand still remains below prior year, that gap is narrowing and new orders are growing at a double-digit rate, with particular strength in our MSP clients.
接下來我們回顧第四季各業務的表現與趨勢。我們的護理與 Allied 部門營收為 3.21 億美元,年增 4%。我們最大業務——旅遊護理派遣——營收年增 8%,成長主要由量的增加所驅動。我們在數位行銷與招募新候選人方面的投資也開始見效,申請人數與新旅遊護理人員到任(new traveler starts)均較去年同期增加。近幾個月,旅遊護理派遣的需求環境呈現改善動能。雖然整體需求仍低於去年同期,但差距正在縮小,新訂單以雙位數成長,且在我們的 MSP 客戶中表現尤為強勁。
In the fourth quarter, the Allied staffing division achieved revenue growth of 6% year-over-year, driven by volume increases. We had double-digit growth in imaging, and the team has done a great job of growing specialties across a variety of settings. MSP clients represented about 45% of this division's revenue, driven by higher fill rate.
第四季,Allied 派遣事業部營收年增 6%,同樣由量的增加所帶動。我們在影像(imaging)領域達成雙位數成長,團隊也在多元場域中成功拓展各項專科。MSP 客戶約占該事業部營收的 45%,主要受較高的填補率(fill rate)帶動。
Looking ahead to the first quarter, the Nurse and Allied segment is expected to be up 7% to 8% year-over-year. In the Locum Tenens segment, fourth quarter revenue of $108 million grew 4% year-over-year. Many specialties sustained growth, though primary care, psychiatry and hospitalists were down. Overall, demand for Locum is strong and slightly above prior year, and we are seeing an increase in MSP wins that include Locum. While we are pleased with the upside results achieved in the second half of 2017, keep in mind that the Locums business is in the midst of a model and technology upgrade. In the near term, these changes have been disruptive to productivity, which is reflected in our first quarter guidance. However, we are confident that the long-term benefits of these changes will justify the short-term impact.
展望第一季,護理與 Allied 部門預期將年增 7% 至 8%。在 Locum Tenens 部門,第四季營收為 1.08 億美元,年增 4%。多數專科維持成長,但基層醫療、精神科與住院醫師(hospitalists)則下滑。整體而言,Locum 的需求強勁,略高於去年同期,我們也看到包含 Locum 的 MSP 得標案增加。雖然我們對 2017 年下半年取得的超預期成果感到滿意,但請注意 Locums 業務正處於商業模式與技術升級之中。短期內,這些變革對生產力造成干擾,並反映在我們第一季的指引中。然而,我們相信這些變革的長期效益將足以抵銷短期影響。
For the first quarter, Locum Tenens revenue is expected to be slightly down year-over-year. Fourth quarter revenue in our Other Workforce Solutions segment was $80 million, which was 5% higher year-over-year. Growth was led by our interim leadership, VMS, health information management and workforce optimization businesses, which collectively grew over 10% year-over-year. Our permanent placement related businesses declined year-over-year, although at a slower rate than last quarter.
第一季 Locum Tenens 營收預期將較去年同期小幅下滑。我們「其他人力解決方案」部門第四季營收為 8,000 萬美元,年增 5%。成長主要由臨時領導(interim leadership)、VMS、健康資訊管理與人力優化業務帶動,這些業務合計年增超過 10%。與永久安置(permanent placement)相關的業務較去年同期下滑,但下滑幅度較上一季放緩。
Interim leadership, which includes B.E. Smith and the First String was up 11% year-over-year. The team has really made great progress on MSP placements, which have reached nearly 20% of the revenue. Our VMS businesses, which are largely vendor-neutral, grew 15%. The team has done a great job of adding new customers and expanding services to meet the changing needs of clients. For example, Medefis launched new capabilities in the fourth quarter to support Locum and nonclinical staffing. ShiftWise also recently launched their next-generation platform. Our health information management business, Peak Health, posted 8% revenue growth. The ramp of new client wins gives us great confidence in continued growth for 2018. Physician Permanent Placement fourth quarter revenue was below prior year by about 10%, but in line with our expectations. This business is regaining its footing, with revenue expected to be down in the single digits year-over-year in the first quarter.
臨時領導業務(包含 B.E. Smith 與 First String)年增 11%。團隊在 MSP 安置方面確實取得重大進展,相關營收占比已接近 20%。我們的 VMS 業務(多為供應商中立)成長 15%。團隊在新增客戶並擴展服務以滿足客戶需求變化方面表現出色。例如,Medefis 於第四季推出新功能,以支援 Locum 與非臨床派遣。ShiftWise 近期也推出其下一代平台。我們的健康資訊管理業務 Peak Health 營收成長 8%。新客戶得標案的爬坡(ramp)讓我們對 2018 年持續成長充滿信心。醫師永久安置(Physician Permanent Placement)第四季營收較去年同期低約 10%,但符合我們預期。該業務正在重回正軌,第一季營收預期將呈現個位數百分比的年減。
Our workforce optimization business, Avantas, had a solid quarter with revenue up double digits over prior year. Consulting and analytics services continue to be in high demand and are differentiating AMN. Building off 2017 momentum, Avantas will introduce a new product release in the first quarter, including mobile functionality and an online analytics dashboard. We feel well-conditioned in this business as we move forward.
我們的人力優化業務 Avantas 本季表現穩健,營收較去年同期呈雙位數成長。顧問與分析服務持續維持高需求,並使 AMN 具備差異化優勢。在 2017 年動能基礎上,Avantas 將於第一季推出新版產品,包括行動功能與線上分析儀表板。我們認為在推進此業務的過程中,已具備良好條件。
Overall, first quarter revenue for the Other Workforce Solutions segment is expected to be up approximately 3% to 4% year-over-year. Our long-term strategy of investing in our talent, technology and workforce solutions is the right thing for all of our stakeholders.
整體而言,「其他人力解決方案」部門第一季營收預期將年增約 3% 至 4%。我們長期策略——投資於人才、技術與人力解決方案——對所有利害關係人而言都是正確的方向。
Recent federal tax reforms have enhanced our ability to reinvest from a position of even greater strength. A substantially lower tax rate increases our cash flow, giving AMN the flexibility to accelerate these growth strategies. Much of the tax benefit will immediately flow through to shareholders in increased earnings. At the same time, we also intend to accelerate investments in key strategic areas such as digital and mobile capabilities, employee productivity tools and process improvements.
近期聯邦稅改提升了我們以更強實力進行再投資的能力。大幅降低的稅率提高了我們的現金流,使 AMN 能更具彈性地加速這些成長策略。多數稅務利益將立即透過獲利提升回饋股東。同時,我們也計畫加速在關鍵策略領域的投資,例如數位與行動能力、員工生產力工具以及流程改善。
We also will be using this opportunity to further increase investment in our team members with a variety of initiatives that will focus on training and development, our work environment and compensation and benefits programs. As an active supporter to many important social and non-profit causes, we will also be increasing our charitable contributions, in alignment with our clients, team members and the needs of our communities. We estimate the increased spending from these initiatives will impact adjusted EBITDA margin by about 20 basis points in 2018, with an EPS impact of about $0.09. We expect the long-term benefits of these investments will more than justify the cost.
我們也將藉此機會,透過多項計畫進一步加大對團隊成員的投資,重點聚焦於訓練與發展、工作環境,以及薪酬與福利方案。作為多項重要社會與非營利事業的積極支持者,我們也將提高慈善捐款,以符合我們客戶、團隊成員以及社區需求的一致方向。我們估計,這些計畫所帶來的新增支出將使2018年調整後EBITDA利潤率約下降20個基點,對每股盈餘(EPS)的影響約為0.09美元。我們預期,這些投資的長期效益將遠超其成本。
Since we created our workforce solutions strategy almost a decade ago, AMN has dramatically evolved our client engagement model. We are earning a more collaborative position in helping our clients manage and optimize their clinical workforce, which is their single largest operating expense. On the talent side, AMN is evolving with the health care workforce in new and better ways. The value we bring to health care professionals is just as important as serving our clients. At the heart of everything AMN does are 3,000 talented and energetic corporate team members. They embody our commitment to doing things right and putting in the extra effort to exceed the expectations of our clients, our health care professionals and the communities we serve.
自我們近十年前制定勞動力解決方案策略以來,AMN已大幅演進我們的客戶互動模式。我們在協助客戶管理並最佳化其臨床勞動力(亦為其最大單一營運費用)方面,正取得更具協作性的角色。在人才端,AMN也正以嶄新且更佳的方式,隨著醫療照護勞動力一同演進。我們為醫療專業人員帶來的價值,與服務客戶同等重要。AMN一切作為的核心,是3,000名才華洋溢且充滿活力的企業團隊成員。他們體現我們致力於把事情做對、並付出額外努力,以超越客戶、醫療專業人員以及我們所服務社區的期望。
Now I will turn the call over to Brian for a financial update, after which, Ralph and Dan will join us for the Q&A section of the call.
接下來我將把電話會議交給Brian進行財務更新;之後Ralph與Dan將加入我們,進入本次電話會議的問答環節。
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Thank you, Susan, and good afternoon, everyone. The company's fourth quarter revenue of $509.1 million was $5 million above the high end of our guidance range, with outperformance in all 3 segments.
謝謝你,Susan,各位下午好。本公司第四季營收為5.091億美元,較我們指引區間上緣高出500萬美元,三大事業部門皆優於預期。
As expected, labor disruption revenue in the quarter was $3 million as compared to $12 million in the prior year. Excluding this labor disruption revenue, fourth quarter consolidated revenue was 6% above prior year. Gross margin for the quarter was 31.8%, down 70 basis points from last year and 50 basis points from last quarter. This year-over-year margin decline was due mainly to lower bill pay spread in Locum Tenens and a lower gross margin in the Other Workforce Solutions segment, due mainly to business mix changes. The sequential gross margin decline was driven by seasonal revenue mix changes, along with a lower Locum Tenens gross margin.
如預期,本季勞動中斷相關營收為300萬美元,去年同期為1,200萬美元。排除該勞動中斷營收後,第四季合併營收較去年同期高出6%。本季毛利率為31.8%,較去年下降70個基點,較上季下降50個基點。此一年對年毛利率下滑主要係因Locum Tenens的帳單與薪酬價差(bill pay spread)降低,以及其他勞動力解決方案事業部門毛利率較低,主要由於業務組合變化所致。季對季毛利率下滑則是由季節性營收組合變化所驅動,並伴隨Locum Tenens毛利率下降。
SG&A expenses in the quarter totaled $100.4 million or 19.7% of revenue, as compared to 20.7% last year and 20.3% last quarter. The improved SG&A margin from the prior year was primarily the result of the operating leverage. Fourth quarter Nurse and Allied segment revenue was $321.4 million, an increase of 4% from the prior year and 6% sequentially.
本季SG&A費用合計1.004億美元,占營收19.7%,去年為20.7%,上季為20.3%。相較去年SG&A利潤率改善,主要是營運槓桿所致。第四季護理與醫事(Nurse and Allied)事業部門營收為3.214億美元,較去年同期成長4%,較上季成長6%。
Volume was higher by 5% year-over-year, while the average bill rate increased by 1%. Nurse and Allied gross margin of 27.4% was 10 basis points higher compared to the prior year and prior quarter. This segment recorded a $2 million favorable professional liability reserve adjustment in both the current quarter and the prior year quarter.
年對年而言,量(Volume)增加5%,平均帳單費率(average bill rate)上升1%。護理與醫事毛利率為27.4%,較去年同期與上季皆高出10個基點。該部門在本季與去年同期皆認列200萬美元的有利專業責任準備金調整。
Fourth quarter Locum Tenens segment revenue of $108.1 million was 4% higher than the prior year and down 3% on a sequential basis. On a year-over-year basis, the average bill rate increased by 6% and the number of days filled was lower by 1%.
第四季Locum Tenens事業部門營收為1.081億美元,較去年同期高出4%,較上季下降3%。以年對年來看,平均帳單費率上升6%,填補天數(days filled)下降1%。
Locum Tenens gross margin of 29.3% was down 150 basis points from the prior year, driven mainly by a lower bill-to-pay spread as position pay rates have been increasing faster than bill rates.
Locum Tenens毛利率為29.3%,較去年同期下降150個基點,主要係因帳單對薪酬價差(bill-to-pay spread)縮小,因為職位薪酬費率的上升速度快於帳單費率。
As a reminder, the Locum Tenens SG&A in the prior year quarter included a favorable professional liability reserve adjustment of over $3 million. Excluding this adjustment, Locum Tenens EBITDA margin was relatively consistent with their prior year but down sequentially on a lower gross margin.
提醒各位,去年同期的Locum Tenens SG&A包含超過300萬美元的有利專業責任準備金調整。排除該調整後,Locum Tenens EBITDA利潤率與去年同期大致一致,但因毛利率較低而較上季下滑。
Fourth quarter Other Workforce Solutions segment revenue of $79.6 million was up 5% year-over-year and down 1% sequentially. Gross margin at 53.1% was lower by 260 basis points year-over-year and 100 basis points sequentially. The year-over-year variance was driven in large part from a lower mix of permanent placement revenue, along with higher direct cost in interim leadership.
第四季其他勞動力解決方案(Other Workforce Solutions)事業部門營收為7,960萬美元,較去年同期成長5%,較上季下降1%。毛利率為53.1%,年對年下降260個基點,季對季下降100個基點。年對年差異主要係因永久安置(permanent placement)營收占比降低,以及臨時領導(interim leadership)直接成本較高所致。
Unallocated corporate overhead in the quarter was $15.5 million, representing 3.1% of revenue, compared to the prior year expense of $18.6 million or 3.8% of revenue. As a reminder, the prior year included an unfavorable legal reserve adjustment. Excluding this, corporate overhead was relatively consistent with the prior year and prior quarter.
本季未分攤的公司總部費用為1,550萬美元,占營收3.1%,去年同期費用為1,860萬美元,占營收3.8%。提醒各位,去年同期包含一項不利的法律準備金調整。排除該項影響後,公司總部費用與去年同期及上季大致一致。
On a consolidated basis, fourth quarter adjusted EBITDA of $64.4 million was up 6% year-over-year and 4% sequentially. The adjusted EBITDA margin of 12.6% was an improvement of 10 basis points over prior year and prior quarter. We reported net income of $41.2 million and diluted earnings per share of $0.84 for the fourth quarter. Adjusted earnings per share was $0.63 compared to $0.62 in the prior year quarter. In calculating adjusted EPS, our tax rate in the quarter was 42%, which was higher than our expected rate of 39%, lowering our EPS by $0.03.
以合併口徑計算,第四季調整後EBITDA為6,440萬美元,較去年同期成長6%,較上季成長4%。調整後EBITDA利潤率為12.6%,較去年同期與上季皆改善10個基點。我們第四季淨利為4,120萬美元,稀釋後每股盈餘為0.84美元。調整後每股盈餘為0.63美元,去年同期為0.62美元。在計算調整後EPS時,本季稅率為42%,高於我們預期的39%,使EPS降低0.03美元。
Our GAAP income tax rate in the quarter was 15%. This included a $14 million tax benefit on the remeasurement of our deferred taxes from the Tax Cuts and Jobs Act. For 2018, in consideration of the tax law changes, the company estimates its effective income tax rate will be approximately 29%.
本季我們的GAAP所得稅率為15%。其中包含因《減稅與就業法案》(Tax Cuts and Jobs Act)對遞延所得稅重新衡量所帶來的1,400萬美元稅務利益。考量稅法變更,對於2018年,公司估計其有效所得稅率約為29%。
Cash provided by operations was $19 million for the quarter and $115 million for the full year, which compares to $132 million in the prior year.
本季營運活動提供的現金為1,900萬美元,全年為1.15億美元,去年為1.32億美元。
The fourth quarter included a $34 million transfer of certain self-insured reserves to our captive insurance entity, which was accounted for as a reduction in our operating cash flow. Excluding this transfer and net of an associated reduction in cash taxes, 2017 operating cash flow was approximately $140 million.
第四季包含將特定自保準備金3,400萬美元轉入我們的自保保險公司(captive insurance entity),在會計處理上列為營運現金流的減少。排除該轉移並扣除相關現金稅負下降後,2017年營運現金流約為1.40億美元。
Days sales outstanding at quarter end was 63 days compared to 64 days in both the last quarter and the last year.
截至季末,應收帳款週轉天數(DSO)為63天,上一季與去年同期皆為64天。
As of December 31, cash and equivalents totaled $15 million. Capital expenditures were $27 million for the full year. At year-end, our total debt outstanding was $325 million and our leverage ratio was 1.3x to 1.
截至12月31日,現金及約當現金合計1,500萬美元。全年資本支出為2,700萬美元。年末我們的未償還總債務為3.25億美元,槓桿比率為1.3倍。
During the fourth quarter, we repurchased 300,000 shares for a total of $13 million. As noted in the press release, we issued earlier this week, on February 9, we entered into a new $400 million revolving credit facility, replacing our previous facility. This 5-year agreement includes improved terms and a reduction in pricing by at least 25 basis points at all leverage levels.
第四季期間,我們回購30萬股,總金額1,300萬美元。如本週稍早(2月9日)發布的新聞稿所述,我們簽訂了一項新的4億美元循環信用額度,取代先前的額度。這項為期5年的協議包含更佳條款,並在所有槓桿水準下至少下調25個基點的定價。
Now let's turn to first quarter 2018 guidance.
接下來我們來看2018年第一季指引。
The company expects consolidated revenue of $516 million to $522 million. This represents top line growth of about 5% year-over-year. There was no labor disruption revenue included in this guidance, nor was there any in the prior-year quarter. Gross margin is projected to be approximately 32%. SG&A expenses as a percentage of revenue are expected to be approximately 20%, and adjusted EBITDA margin is expected to be 12.5% to 13%.
公司預期合併營收為5.16億至5.22億美元,約為年對年5%的營收成長。本指引未包含任何勞動中斷營收,去年同期亦無。毛利率預估約為32%。SG&A費用占營收比重預期約為20%,調整後EBITDA利潤率預期為12.5%至13%。
Other first quarter 2018 estimates include the following: Interest expense of $4.7 million, excluding any one-time expenses related to the new credit facility; depreciation expense of $3.7 million; amortization expense of $4.4 million; stock-based compensation expense of $2.9 million; and diluted share count of 49.1 million shares.
2018年第一季其他估計如下:利息費用470萬美元(不含與新信用額度相關的任何一次性費用);折舊費用370萬美元;攤銷費用440萬美元;股份基礎給付費用290萬美元;以及稀釋後股數4,910萬股。
Before we open up the call for questions, I just want to echo Susan's appreciation for the great work of our AMN team. Their passion for our clients, health care professionals and each other is the key to AMN's success. And we're excited to be investing more going forward and helping them achieve their professional and personal goals as part of the AMN family.
在我們開放提問之前,我想再次呼應Susan對AMN團隊出色工作的感謝。他們對客戶、醫療專業人員以及彼此的熱忱,是AMN成功的關鍵。我們也很期待未來加大投資,協助他們作為AMN大家庭的一員,達成其職涯與個人目標。
And with that, we'd like to open up the call for questions.
接下來,我們將開放提問。
Operator
Operator
(Operator Instructions) Our first question, from the line of Tobey Sommer with SunTrust Robinson Humphrey.
(接線員指示)我們的第一個問題,來自SunTrust Robinson Humphrey的Tobey Sommer。
Tobey O'Brien Sommer - MD
Tobey O'Brien Sommer - MD
I was wondering if you could review the importance of new orders versus total orders? And I think I've got a grasp on it, but we do talk about both metrics when it seems like new orders are fresh and likely to be filled and some of the orders that have been around for a while may be a bit stale and kind of not that pertinent?
我想請您回顧一下新訂單相較於總訂單的重要性?我覺得我大致理解,但我們確實同時談到這兩個指標;看起來新訂單是新進的、較可能被填補,而有些存在一段時間的訂單可能有點「陳舊」,也不那麼相關,對嗎?
Dan White - President of Strategic Workforce Solutions
Dan White - President of Strategic Workforce Solutions
Tobey, it's a good question. You're right, we have begun to emphasize, even more so over the last probably 8 quarters, the importance of new orders versus the total order count. Within the total order count we have, they may not be stale but you have orders that are extremely difficult to fill or ones that maybe the client is less serious about filling and so, sometimes, that number is a little bit less predictable of our future than the new orders are. We've begun to kind of pay quite a bit more attention to new orders in terms of determining our trend. The new orders are strong. I think we talked about it being up double-digit in our Travel Nurse business. They also were up recently in our Allied business and demand is good on our Locum's business as well. So I think that's why you hear some confidence about moving forward in our forecast as well as probably in our tone. The one other thing on the total order count that I think is important, during the time of dramatic growth, the industry didn't have the capacity to grow at the rate that client needs for growing, and that capacity has been built up, particularly like us, increasing the number of recruiters we have. And so, therefore, the total orders may never actually get back to some of the all-time highs. It doesn't mean we couldn't grow really fast, it's just they get filled more quickly. So I think we talked about this last call, we were a couple of days faster in filling orders. Again, this quarter, we're another day quicker in filling orders, so those are all positive things for our business.
Tobey,這是個好問題。你說得對,過去大概 8 個季度,我們開始更強調新訂單相較於總訂單數的重要性。在總訂單數裡,未必是陳舊,但確實會有一些訂單非常難以填補,或是客戶其實沒那麼認真要填補,所以有時候那個數字對我們未來的可預測性,會比新訂單來得低一些。我們開始在判斷趨勢時更關注新訂單。新訂單表現強勁。我想我們提到過,在我們的旅遊護理(Travel Nurse)業務中,新訂單是兩位數成長。最近在我們的 Allied 業務也在成長,而我們的 Locum's 業務需求也不錯。所以我想這就是為什麼你會聽到我們在往前看的預測以及語氣上都更有信心。關於總訂單數,還有一點我覺得很重要:在產業快速成長的期間,整個產業的產能無法以客戶需求成長的速度擴張,而這個產能已經建立起來了,尤其像我們增加了招募人員的數量。因此,總訂單數可能永遠不會回到某些歷史高點。這不代表我們不能快速成長,只是訂單被填補得更快。我想我們在上次電話會議也談到,我們填補訂單的速度快了幾天。而這一季,我們又快了 1 天,所以這些對我們的業務都是正面的。
Tobey O'Brien Sommer - MD
Tobey O'Brien Sommer - MD
Great. Could you expand on the comments you made about maybe some of the leading indicators for Locums being encouraging to you beyond the 1Q guide since you did just do a system migration?
很好。你能否再延伸說明一下,你提到的、在 1Q 指引之外讓你覺得 Locums 的一些領先指標令人鼓舞的部分?因為你們確實剛做了系統遷移。
Dan White - President of Strategic Workforce Solutions
Dan White - President of Strategic Workforce Solutions
Yes, we are in the process of this system migration. Actually takes place beginning of Q -- or sorry, end of Q1 through almost all of Q2. And with that, there's process changes that come that we've been implementing over the last probably, I guess, 3 months now. Things were -- people's roles changed to become -- to move more into roles where their skills matter more, so they're selling skills versus kind of admin skills. A lot of the admin work goes away with the technology. Back to your original question of leading indicators, we are seeing an increase in the demand based on the number of days our clients are requesting from us in the Locums business. I would -- I wish it was in our sweet spot, it's a little bit in more difficult to fill specialties, so things like psychiatrists, we're seeing cRNAs, those are growing pretty fast and give us confidence. They're just, right now, they take us a little longer to fill, and hence, also, have a slight impact on our margin as recruiters try to get clinicians into those assignments and sometimes have to pay a little bit more to get them there.
是的,我們正在進行這次系統遷移。實際上是從 Q1 的結束開始——抱歉,是從 Q1 末一路到幾乎整個 Q2。伴隨而來的是流程變更,我們在過去大概 3 個月一直在推動。事情是——人員的角色有所調整,轉向更能發揮其技能的職務,所以他們是在銷售專業技能,而不是偏行政性的技能。很多行政工作會因為科技而消失。回到你原本問的領先指標,我們看到 Locums 業務中,基於客戶向我們要求的服務天數增加,需求正在上升。我會——我希望它落在我們的甜蜜點,但目前更多是在較難填補的專科;例如精神科醫師,我們也看到 cRNA(麻醉護理師)成長很快,這些都讓我們更有信心。只是目前填補所需時間稍長,因此也會對我們的毛利率有些微影響,因為招募人員要把臨床人員安排進這些派遣,有時必須支付更高的費用才能讓他們到位。
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Tobey, probably the other strong indicator we have around demand and our ability to execute well on that demand is the strength that we see in more Locum's contracts with 4 MSP clients. And we have the strongest pipeline we've ever seen in terms of clients wanting to migrate to their first MSP arrangement and through us ideally. And so that tells us that they see the demand continuing for Locums. And obviously, we perform well in those environments.
Tobey,另外一個關於需求以及我們執行該需求能力的強力指標,是我們在與 4 家 MSP 客戶的更多 Locum's 合約上看到的強勁表現。而且就客戶希望首次導入 MSP 安排、並理想上透過我們來進行而言,我們看到的是史上最強的案源管線。這告訴我們,他們認為 Locums 的需求會持續。當然,我們在那樣的環境中表現也很好。
Tobey O'Brien Sommer - MD
Tobey O'Brien Sommer - MD
Great. And then, maybe a question for Brian and I'll get back in the queue. Brian, could you talk about cash flow conversion in '17 and maybe what your outlook is for cash flow conversion from EBITDA in '18?
很好。接著可能問 Brian 一個問題,我之後再回到隊列。Brian,你能談談 2017 年的現金流轉換率,以及你對 2018 年 EBITDA 轉換為現金流的展望嗎?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Sure. As I mentioned in the prepared remarks, the cash flow in 2017 was dampened a bit by that transfer we made into our captive. Otherwise, it would have been a nice growth from 2016 to 2017, mirroring the growth in the EBITDA as well. So historically, we've been more in the kind of 40% to 50% conversion of EBITDA to operating cash flow. It will be north of 60%. There's always going to be some variation with working capital, but just through the tax rate reduction, that will be north of 60% going forward.
當然。如同我在事先準備的發言中提到的,2017 年的現金流因為我們轉入自保(captive)的一筆移轉而稍微受到壓抑。否則,從 2016 到 2017 會是相當不錯的成長,並且也會反映 EBITDA 的成長。歷史上,我們 EBITDA 轉換為營運現金流大概在 40% 到 50% 的區間。未來會高於 60%。營運資金一定會造成一些波動,但僅就稅率下降這一點,往後就會高於 60%。
Tobey O'Brien Sommer - MD
Tobey O'Brien Sommer - MD
And how much of that north -- how much of that delta is a function of the tax rate change versus the normal...
那個「高於」——那個差額有多少是稅率變動造成的,而不是正常的……
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
That's the majority of it. Otherwise, I mean, the EBITDA margin obviously is going to -- will go up over time a little bit, but the kind of the vast majority of that is really being driven by the lower tax rate.
大部分都是。除此之外,我是說,EBITDA 利潤率顯然會——隨時間略有上升,但其中絕大多數其實是由較低的稅率所驅動。
Operator
Operator
And our next question, from the line of Jeff Silber with BMO Capital Markets.
下一個問題,來自 BMO Capital Markets 的 Jeff Silber。
Jeffrey Marc Silber - MD & Senior Equity Analyst
Jeffrey Marc Silber - MD & Senior Equity Analyst
The media has been paying a lot of attention to the flu outbreak this season. I'm just curious, what impact you think it had on your business last quarter and what's embedded in your guidance for the current quarter?
媒體這一季對流感爆發非常關注。我想了解的是,你們認為它對上季業務造成了什麼影響?以及你們在本季指引中納入了哪些影響?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Thanks for the question, Jeff. We get asked this, I think, every year, but particularly in a year like this where we know there's been a greater epidemic and impact. We really didn't hear the same thing even directly from our clients, but it's interesting that it doesn't seem to have a material impact on our business. It's very difficult -- to be fair, it's very difficult for us to measure exactly the reason for every order coming in, but the places that you see it most predominantly would be in local staffing as well as our rapid response businesses. Our best estimate would be, in the fourth quarter, we might have seen an extra $1 million to $2 million from incremental flu-related business and similarly in the first quarter. Now remember, in the fourth quarter, however, we also had a negative impact from the hurricanes at the beginning of October. And so those 2 probably somewhat offset each other in the fourth quarter. If you were going to bake anything into the first quarter, it would be, at best, we think, $1 million to $2 million.
謝謝你的問題,Jeff。我想我們每年都會被問到這個,尤其像今年這樣,我們知道疫情更嚴重、影響更大。有趣的是,我們其實沒有從客戶那邊直接聽到同樣的說法,但看起來它對我們的業務並沒有實質性的影響。公平地說,我們很難精確衡量每一筆訂單進來的原因,但你最可能看到影響的地方會是在本地派遣(local staffing)以及我們的快速應變(rapid response)業務。我們最佳估計是,在第四季,流感相關的增量業務可能多了 100 萬到 200 萬美元,第一季也差不多。請記得,不過在第四季,我們也受到 10 月初颶風的負面影響。所以這兩者在第四季可能在某種程度上互相抵銷。如果要把任何因素納入第一季,我們認為最多也就是 100 萬到 200 萬美元。
Jeffrey Marc Silber - MD & Senior Equity Analyst
Jeffrey Marc Silber - MD & Senior Equity Analyst
Okay. Great. That's very helpful. Shifting gears to the Locum Tenens business, I understand your guidance for revenue to be down slightly. I know you're not giving guidance beyond the current quarter. But is it realistic to expect that business to start growing again in the near future?
了解。很好,這很有幫助。把話題轉到 Locum Tenens 業務,我理解你們的指引是營收會小幅下滑。我知道你們不提供超過本季的指引。但在不久的將來,合理期待這個業務會重新回到成長嗎?
Ralph S. Henderson - President of Professional Services and Staffing
Ralph S. Henderson - President of Professional Services and Staffing
This is Ralph. It's a good question, Jeff. It surprised us on the upside in Q3 and in Q4 from our original projections. So the new leadership, the changes they're making, the ability to shift their focus quickly on recruiting new specialties and in new markets, the expansion of the physician license, there's lots of really good things going on. As a matter of fact, we saw demand increase in 7 of the specialties, with only 4 being down in the fourth quarter. So it is reasonable to expect us to get back to growth. Predicting how much disruption we have, I mean, you have people who are in new roles using a new piece of technology and exactly when they'll exit that is -- I wish there was a science around it as we would answer the question. So we've been kind of leaning toward seeing growth more towards the fourth quarter of the year, after the changes have taken effect and had the people had 2 or 3 months with the new technology and in their new roles. And we expect to be positive, both from a revenue and a margin perspective.
我是 Ralph。這是個好問題,Jeff。它在 Q3 和 Q4 相較於我們原先的預測都帶來了上行驚喜。所以新管理團隊、他們正在推動的變革、能夠快速把重心轉向招募新的專科與新市場、醫師執照的擴張,很多事情都在往好的方向走。事實上,我們在第四季看到 7 個專科的需求增加,只有 4 個下滑。所以合理來說,我們有機會回到成長。至於會有多少干擾,我是說,你有一些人處在新角色、使用新的技術工具,而他們何時能走出這段過渡期——我希望這有一門科學可循,這樣我們就能回答得更精準。因此我們比較傾向於認為,成長會更偏向在今年第四季出現,等變革生效、而且人員在新技術與新角色上運作了 2 到 3 個月之後。我們預期無論在營收或利潤率角度都會轉為正向。
Jeffrey Marc Silber - MD & Senior Equity Analyst
Jeffrey Marc Silber - MD & Senior Equity Analyst
Okay. Great. That's helpful. And then, just a couple of numbers question. Brian, you talk about a refinancing. Is it possible to give us some sort of guesstimate what the impact is going to be on interest expense going forward? Or should we just use the first quarter guidance number as the run rate for the rest of the year?
了解。很好,這很有幫助。最後再問幾個數字問題。Brian,你提到再融資。是否可以給我們一個大概的估算,未來利息費用會受到什麼影響?或者我們應該把第一季指引的數字當作今年其餘時間的常態水準(run rate)?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Yes. Even the first quarter is at a reasonable expectation. Keep in mind, we have $325 million unsecured [revolver], which that is the majority of the interest expense we have today, and that will continue forward. The new facility is undrawn at this point. So it has really no material impact at all on our run rate interest expense going forward. One of the things we generate more cash through the year, we can actually create some interest income, so there could be a little bit of a reduction in the interest expense, but the $4.7 million for the first quarter might go down to $4.6 million, $4.5 million by the end of the year.
是的。即使第一季也符合合理的預期。請記住,我們有 3.25 億美元的無擔保[循環信貸額度],這構成了我們目前利息費用的大部分,而且未來也會持續。新融資安排目前尚未動用,因此對我們未來的利息費用常態水準幾乎沒有任何重大影響。隨著我們在一年中產生更多現金,我們其實也可能產生一些利息收入,因此利息費用可能會略有下降;第一季的 470 萬美元到年底可能會降到 460 萬美元、450 萬美元。
Jeffrey Marc Silber - MD & Senior Equity Analyst
Jeffrey Marc Silber - MD & Senior Equity Analyst
Okay. Great. That's fair. And then, one final one. What should we be modeling for capital expenditures for the current year?
好的。很好。這很合理。然後最後一個問題,今年的資本支出你們建議我們在模型中假設多少?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
I think, mid-20s. So we had $27 million as we talked about in 2017, it will likely be a similar level in 2018. One is we continue with the implementation as with Locums going live as Ralph talked about. And then, we have work to do for Nursing and Allied through this year. We're also continuing to invest in some of the areas that Susan alluded to around some of our digital and mobile capabilities and some of the initiatives that we have in line for kind of accelerating some of our growth strategies. So into that -- through all that, it'll probably end some being somewhere in the mid-20s again.
我認為大約在 2,000 多萬美元的中段。我們如同先前談到的,2017 年是 2,700 萬美元,2018 年很可能會是相近水準。一方面,我們會持續推進導入作業,正如 Ralph 提到的 Locums 上線。另一方面,今年我們也需要為 Nursing 和 Allied 做一些工作。我們也會持續投資 Susan 提到的部分領域,包括我們的數位與行動能力,以及一些用來加速成長策略的相關計畫。綜合以上,最後大概還是會落在 2,000 多萬美元的中段。
Operator
Operator
And our next question, from the line of Mark Marcon with R.W. Baird.
下一個問題來自 R.W. Baird 的 Mark Marcon。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Wondering, with regards to Nurse and Allied, I mean, you're projecting a pickup in terms of the growth rate. What's the primary attribution to -- is it the growth that you're seeing on the MSPs? Is there any more unexpected pickup in terms of orders or any sort of regional variances? And then, I've got a few others.
想請教關於 Nurse 和 Allied,你們預期成長率會回升。主要歸因是什麼——是你們在 MSP 看到的成長嗎?是否有任何超出預期的訂單回升,或任何區域性的差異?另外我還有幾個問題。
Ralph S. Henderson - President of Professional Services and Staffing
Ralph S. Henderson - President of Professional Services and Staffing
This is Ralph. I'll start and sure others in the room may want to talk more about this. You're spot on. The MSP demand is up more than other demand. So there's a very favorable mix there. Obviously, higher fill rates we have on our MSP orders, that helps accelerate the demand increase into revenue. And then, the -- really no other kind of refill changes. I mean, things are strong in California, New York, Florida, Texas, places where we are particularly strong geographically. And in specialties where we're good, we've talked about this before, med surg, tele, ICU, we have extremely high internal fill rate. So I -- actually, a little bit of the story as well in Allied, MSP volume increasing, so kind of a favorable shift to MSP there and higher fill rates in our Allied business as well. So that's -- those 2 factors are probably the main drivers for the Nurse and Allied growth.
我是 Ralph。我先回答,房間裡其他人也可能想補充。你說得很準,MSP 的需求成長高於其他需求,因此組合非常有利。當然,我們在 MSP 訂單上的填補率更高,這有助於把需求的增加更快轉化為營收。除此之外——其實沒有其他那種補單(refill)方面的變化。我的意思是,加州、紐約、佛羅里達、德州等我們地理上特別強勢的地區表現都很強;在我們擅長的專科領域,我們之前也談過,例如內外科(med surg)、遠距(tele)、加護病房(ICU),我們的內部填補率非常高。所以——另外 Allied 方面也有一點同樣的故事:MSP 量在增加,因此那邊也出現有利的 MSP 組合轉移,而且我們 Allied 業務的填補率也更高。所以這兩個因素大概是 Nurse 和 Allied 成長的主要驅動。
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
And some of that connects back to the fact that we had an exceptionally strong year in 2017 in winning new MSPs. The majority of those were nursing and Allied, we certainly had some Locums in there as well. And those MSPs were won later in the year than actually we might have wanted. However, they are now rolling out in 2018. And so we'll actually see the majority of the benefit from those wins in '18 and '19. So we're starting to get some of that benefit in the first quarter.
其中一部分也與我們在 2017 年贏得新 MSP 的表現特別強勁有關。這些 MSP 的大多數是在護理與 Allied,我們當然也有一些是 Locums。不過,這些 MSP 的得標時間比我們理想中更偏向年底。然而,它們現在正在 2018 年逐步上線。因此,我們會在 2018 年與 2019 年看到大部分的得標效益。我們在第一季已開始看到其中一些效益。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Great. And then, with regards to the new orders accelerating, can you give us a feel for like what the pace of the new orders are increasing on a year-over-year basis so far this year? And how does that look in terms of just if you were looking at it sequentially by month? Is it -- is the pace increasing at an accelerating rate?
很好。接著,關於新訂單加速,你能否讓我們了解一下今年迄今新訂單年增的速度大概是多少?如果按月度序列來看,情況如何?這個速度是否正在以更快的幅度加速?
Ralph S. Henderson - President of Professional Services and Staffing
Ralph S. Henderson - President of Professional Services and Staffing
Mark, this is Ralph. We do that -- we look at it in 2 ways. One is like a 13-week rolling trend and the other is a 4-week rolling trend. And probably as much flavor as we could give is that the 4-week rolling trend, which is the most recent trend, is stronger than the 13-week trend.
Mark,我是 Ralph。我們用兩種方式看:一是 13 週滾動趨勢,另一是 4 週滾動趨勢。我們能提供的大概是:4 週滾動趨勢(也就是最新的趨勢)比 13 週趨勢更強。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Okay. And how much is the 4-week rolling trend up?
好的。那 4 週滾動趨勢上升了多少?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
That's, I think, a level of granularity that we typically don't provide publicly. Sorry, Mark. Nice try.
我想那種細緻程度我們通常不會對外公開。抱歉,Mark。你很會試。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
I got to try. My sense is things are getting stronger. Just I -- we'll talk off-line about that. In terms of the Locum Tenens, the gross margins there, the expectation longer term is for that to go up. Is that still a reasonable expectation? Is there something that's going on from a very -- from a short-term perspective that's driving the gross margins down? Or is that maybe a function of MSP but the EBITDA margins should eventually even out? Just how should we think about that?
我得試試看。我感覺情況正在變得更強。只是我——我們之後私下再聊。關於 Locum Tenens,那邊的毛利率,長期預期是會上升,這仍然是合理的預期嗎?短期來看是否有什麼因素在壓低毛利率?或者這可能是 MSP 的影響,但 EBITDA 利潤率最終應該會拉平?我們應該怎麼看待?
Ralph S. Henderson - President of Professional Services and Staffing
Ralph S. Henderson - President of Professional Services and Staffing
Yes, good question. We -- our long-term view is still that margin in that business ought to be around 32%, kind of our target long term. We certainly were disappointed to fall below that. You're right. In the past, right, we've had to pay a little bit more to implement new MSP business and that dropped our margins for some period of time. That's not really what happened here. We've just seen a kind of a mix in specialties and also just the disruption of having team members who are -- they're testing software, they're in training, and so they don't have that same amount of time to focus on it. So the physician pay rates are just -- grew just a little bit faster than the client bill rate. And the good news is they recognize the issue and we're starting to, even in the last few weeks, see improvements in the trends that are coming out. It's going to take us a while though to get through it because those -- people are on assignment a long time in that business.
是的,問得好。我們的長期看法仍然是,那個業務的利潤率應該在約 32% 左右,這是我們的長期目標。我們確實對低於該水準感到失望。你說得對,過去我們在導入新的 MSP 業務時,確實需要多付出一些成本,因而在一段時間內壓低利潤率。但這次並不是那樣。我們看到的是專科組合的變化,以及團隊成員受到一些干擾——他們在測試軟體、接受訓練,因此沒有同樣多的時間專注在業務上。所以醫師的支付費率(physician pay rates)成長比客戶的計費費率(client bill rate)快了一點。好消息是,他們已經意識到這個問題,而且我們甚至在最近幾週開始看到趨勢改善。不過要完全改善還需要一些時間,因為那個業務的派遣任期通常很長。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
Okay. Great. And then, just what are you seeing in terms of wage and bill rate inflation? It sounds like wage inflation is picking up, broadly speaking. And so therefore, in an area where there are shortages, you would expect it to be even higher. And I'm wondering if you could also discuss your internal staff and what you're seeing there in terms of pressures?
好的。很好。那麼,你們在薪資與計費費率通膨方面看到什麼?聽起來整體而言薪資通膨正在升溫。因此在供給短缺的領域,你會預期更高。我也想請你談談你們內部員工,在壓力方面你們看到什麼?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Sure. This is Brian. so we've talked a bit about the physician market, which is a little more dynamic as you're kind of negotiating pay and bill rate as you're making placements. And so we've seen more of it there. On the Nursing and Allied side, I'd say we haven't necessarily felt the same type of wage pressure of late that you may be hearing more in a broader permanent side. And I think that's probably a reflection of the growth we've seen in pay over the last couple of years through the (inaudible) increases as we try to bring more supply into the industry. So we're probably a little bit ahead of that, and so we're feeling in a good place right on the balance between supply and demand and compensation packages being very attractive as an industry. So I wouldn't equate those 2 things exactly to what you're hearing on a permanent side. Internally, I think, you're hearing generally a little more wage inflation across the U.S. We certainly feel some of that. However, we tried to stay on top of that over the last couple of years as well. Susan talked about with the tax reform, we are using this as an opportunity to invest in our team members. They're kind of the lifeblood of how we operate every day and we want to make sure we're giving them the tools, the training, development and compensation and benefits to make sure that we're the employer of choice. And so that, I think, will -- that will help us stay kind of at or ahead of the curve relative to our competition.
當然。我是 Brian。我們談過一些醫師市場,那邊更具動態性,因為你在做派遣配置時會同時協商支付與計費費率,所以我們在那邊看到的變化更明顯。至於 Nursing 和 Allied,我會說我們最近未必感受到你可能在更廣泛的永久職(permanent)市場聽到的那種薪資壓力。我認為這可能反映了過去幾年我們為了把更多供給帶進產業,支付水準已經成長((inaudible) increases)。所以我們可能在那方面稍微走在前面,因此目前在供需平衡以及薪酬方案對人才的吸引力上,我們覺得處於不錯的位置。所以我不會把這兩者完全等同於你在永久職市場聽到的情況。內部方面,我想你也聽到美國整體薪資通膨略有上升,我們確實也感受到一些。不過,我們過去幾年也努力保持領先。Susan 提到稅改,我們正把這視為投資團隊成員的機會。他們是我們每天營運的命脈,我們希望確保提供工具、訓練、發展,以及薪酬與福利,讓我們成為首選雇主。我認為這將有助於我們相對於競爭對手,維持在曲線上或領先。
Mark Steven Marcon - Senior Research Analyst
Mark Steven Marcon - Senior Research Analyst
So there's still high level of confidence in terms of getting to the 14% EBITDA margin?
所以對於達到 14% EBITDA 利潤率仍然很有信心?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Yes.
是的。
Operator
Operator
And we have a question from Tim McHugh with William Blair.
我們有一個問題來自 William Blair 的 Tim McHugh。
Timothy John McHugh - Partner & Global Services Analyst
Timothy John McHugh - Partner & Global Services Analyst
Just on Workforce Solutions, you talked about perm starting to show, I guess, a little bit of signs of improvement. And the trend in the rest of your business sound strong. So can you reconcile that with, I guess, as we go into next year, 3%, 4% growth, just -- I guess, it would feel like it should be stronger based on the qualitative commentary.
關於 Workforce Solutions,你們提到永久職(perm)開始出現一些、我想是些微改善的跡象。而你們其他業務的趨勢聽起來很強。那麼,這與你們在展望明年時提到的 3%、4% 成長要如何對照?就是——我想,根據這些質性評論,感覺成長應該會更強一些。
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Hey, Tim. This is Brian. I will cover that one first and if Susan want to follow along. But it's not obviously much different than the fourth quarter actuals. But the perm is improving. It's still down year-over-year, that's been added as a drag. Our other business lines are all performing well. We look at leadership in the [VMS] and Avantas, but they have really -- they have very strong fourth quarter. So those growth rates will be down just a little bit in the first quarter but still strong overall. But then, kind of net all those together and you end up with a slightly lower rate of growth in the first quarter. I think, as we move through the year and continue to see those perm trends improve, that will move up that consolidated (inaudible) workforce solutions growth rate more into the upper, single or double-digits as we would expect it to be running in normal environment.
嗨,Tim。我是 Brian。我先回答這一題,如果 Susan 也想補充的話也可以。不過這顯然和第四季的實際結果差異不大。但永久派遣(perm)正在改善。它仍然是年減,這也被納入為一項拖累。我們其他業務線的表現都很好。我們看到在 [VMS] 和 Avantas 的領先地位,但它們第四季確實——第四季非常強勁。因此,第一季的成長率會小幅下降一些,但整體仍然強勁。不過把這些因素加總起來,第一季的成長率會略低一些。我認為,隨著我們在今年持續看到 perm 趨勢改善,整體(聽不清)人力解決方案的成長率將會回升到較高的個位數甚至雙位數,符合我們在正常環境下對其應有表現的預期。
Timothy John McHugh - Partner & Global Services Analyst
Timothy John McHugh - Partner & Global Services Analyst
Okay. And then, can you just comment on the, I guess, the acquisition environment given -- and how you think about how aggressive to be with buybacks as we go into next year given where the balance sheet is trending at this point?
好的。接著,能否請你評論一下——我想是——在目前這樣的情況下的併購環境?以及考量到資產負債表目前的走勢,展望明年你們對回購要多積極是怎麼思考的?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Tim, maybe I'll start with the acquisition environment and our strategy there and then we can talk more about where that leaves us with buybacks. So we still are actively looking and, as you would expect, having discussions with a variety of organizations, some of which are so-called on the market and others that we're having more preliminary conversations with about potential opportunities down the road. And it's primarily around acquisitions that can help us to enhance and expand our workforce solutions portfolio, but it could also be creating more scale and capabilities within some of our existing businesses where we feel that, that would benefit us and our clients. And then, third would be potential consolidation opportunities. And I would put them in that exact order. As you would expect, the workforce solutions opportunities are fewer and likely more expensive. Most of them have a technology element to them and that is part of what makes them very attractive and that they have, at maturity, at least more recurring revenue and higher margins, but many of them are also very early stage and may even be pre-profitability. And so we've always been very careful about that to make sure that we enter a service line or a product at the right time with the greatest level of certainty for success. So we're evaluating a whole host of those opportunities. I would say that valuations are stronger than what we've seen in the past. It's true for everybody, including us. And so we have to be willing to step up to those valuations within reason. But you know us, we've always been very disciplined and that's why we've perhaps not pursued certain things. But I would characterize it as very active and a nice number of very attractive opportunities and I would expect that there will be more as we continue through the year. We will also, by the way, look at some minority investments. We've done one so far in a digital online staffing business, and we will potentially look at others. It's not our preference, but sometimes, it's appropriate and we'll make that decision. We still have a buyback in place that the board has authorized and still have actually the majority of that available, and so you would expect that we'll be using that as we see appropriate when we can be opportunistic in the market.
Tim,也許我先從併購環境與我們的策略談起,然後我們再多談談這對回購的影響。所以我們仍在積極尋找機會,而且如你所預期的,我們正與各式各樣的組織進行討論,其中有些是所謂正在市場上尋求交易的標的,另一些則是我們就未來潛在機會所進行的較初步對話。主要聚焦在能協助我們強化並擴展人力解決方案產品組合的併購,但也可能是在我們某些既有業務中建立更大的規模與能力,我們認為那將使我們與客戶受益。第三則是潛在的整併機會。我會把它們依照這個順序排列。如你所預期,人力解決方案的機會較少,且可能更昂貴。多數都帶有科技元素,這也是它們非常吸引人的一部分原因:在成熟後至少會有較多的經常性收入與更高的利潤率,但其中許多也仍處於非常早期階段,甚至可能尚未獲利。因此我們一向非常謹慎,確保我們在正確的時間點、以最高的成功確定性進入某個服務線或產品。我們正在評估一整套這類機會。我會說估值比我們過去看到的更強,這對所有人都一樣,包括我們。因此在合理範圍內,我們必須願意接受更高的估值。但你也了解我們,我們一向非常自律,這也是為什麼我們可能沒有追逐某些案子。不過我會形容目前非常活躍,有相當多非常具吸引力的機會,而且我預期隨著今年推進,機會還會更多。順帶一提,我們也會看一些少數股權投資。我們目前已做了一筆,投資在一家數位線上派遣(staffing)業者,未來也可能再看其他案子。這不是我們的偏好,但有時候是合適的,我們會做出判斷。我們仍有董事會核准的回購計畫,而且其中其實大部分額度仍可用,因此你可以預期,當我們認為合適、且能在市場上把握機會時,我們會使用該回購額度。
Operator
Operator
And we have a question from A.J. Rice with Crédit Suisse.
接下來我們有一題來自瑞士信貸(Crédit Suisse)的 A.J. Rice。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
Just a couple questions if I could ask. So -- and some of these are sort of detailed number questions, but so the tax rates forecast to follow that 11 percentage points from 40% to 29% largely because of the tax reform, obviously. I guess, the statutory rates dropping 14 percentage points, is there any reason why wouldn't it drop a little more than what you've said? Is there some offset that -- in the tax law that we should think about?
如果可以的話我問幾個問題。有些算是比較細的數字問題。你們預估稅率會從 40% 降到 29%,大約下降 11 個百分點,顯然主要是因為稅改。我想法定稅率下降了 14 個百分點,有沒有什麼原因使得它不會比你們說的再多降一些?稅法裡是否有什麼抵銷項目是我們需要考量的?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Sure, A.J. This is Brian. I know there's been a few pieces noise in our tax rate in the last couple of years, but our -- again, our underlying rate, if you were to remove that in 2017, is closer to 41%. There are some discrete items that are industry-related that keep our rate above that. We typically think of a more statutory rate of around 39% kind of under the old tax. So if you take that as the starting point, the 14% federal reduction, it also reduces the shield on the state rate, so the net of that is about 13%. There are a few other items in the new tax code that have a modest increase in the rate as well. So you kind of take all those together, that's where you end up, closer to 29%.
當然,A.J. 我是 Brian。我知道過去幾年我們的稅率有一些雜訊項目,但我們——再說一次,如果你把 2017 年的那些項目剔除,我們的基礎稅率更接近 41%。有一些與產業相關的一次性(discrete)項目使得我們的稅率高於那個水準。在舊稅制下,我們通常把較接近法定的稅率視為大約 39%。如果以此作為起點,聯邦稅率下調 14%,同時也會降低州稅的抵減效果(shield),兩者相抵後約為 13%。新稅法中還有幾個其他項目也會使稅率小幅上升。把這些加總起來,最後就會落在更接近 29%。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
And do you have a figure for how much cash benefit you're going to get from the tax reform, roughly, do you think, this year?
那你們有沒有一個數字,說明今年大概會從稅改獲得多少現金利益?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
It will be in the 25-ish range.
大約會在 25 左右。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
Okay. All right. And you said you're going to plow obviously back in some initiatives to enhance employees and digital tools and so forth. Did I get the number right? You're saying that's a 20 basis points drag on EBITDA. Is that right?
好的。好。你提到你們顯然會把其中一部分再投入一些計畫,用來強化員工與數位工具等等。我有沒有記對數字?你是說這會對 EBITDA 造成 20 個基點的拖累,對嗎?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Yes, that's correct.
是的,沒錯。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
And is that -- so the 12 6 for the first quarter reflects a 20 basis point drag from these investments?
那這樣——第一季的 12 6(應為 12.6)是否反映了這些投資帶來的 20 個基點拖累?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Not really. So we're just starting to -- we've been working through those ideas and so more of them will roll out in the second quarter and beyond. So a very modest impact in the first quarter but it will still -- if you look at kind of the quarters through the rest of the year, we wouldn't expect at this point for it to be more than 20 basis points in any one quarter but that's kind of how it rounds out for the full year as well.
不完全是。我們才剛開始——我們一直在梳理這些想法,因此更多內容會在第二季及之後推出。所以第一季影響非常有限,但如果你看今年其餘季度,我們目前不預期任何單一季度會超過 20 個基點,不過全年加總大致也就是這樣的幅度。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
Okay. And then, on the SG&A side, you're down 100 basis points as a percent of revenues, I think, in the fourth quarter. And I know you have a seasonal step up often in, I think, SG&A going into the first quarter, but you're down 50 basis points in the first quarter year-to-year. Any -- where are you at on SG&A? Was there anything unusual in the fourth quarter? And what's driving the improvement? And what is the outlook, do you think, looking out a little longer term?
好的。接著在 SG&A 方面,第四季你們的 SG&A 佔營收比重下降了 100 個基點,我想是這樣。我也知道你們通常在進入第一季時 SG&A 會有季節性的上升,但你們第一季仍年對年下降了 50 個基點。你們目前對 SG&A 的狀況如何?第四季有沒有什麼不尋常的項目?改善的驅動因素是什麼?以及拉長一點看,你認為展望如何?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Sure. This is Brian again. So in the fourth quarter, I mentioned that there was an actuarial benefit in the Nurse and Allied segment, but we also had some other reserve increases, so the net of all that was pretty nominal. So the fourth quarter was relatively clean from an SG&A standpoint. And the guidance we've given in the first quarter, there's nothing unusual in that. So I think, it's a reasonable starting point for the year. We would expect over time to generate leverage. But in the near term, we also -- we could generate more leverage, we're also investing in the business and investing in some of these initiatives as well. You may not see quite as much of that operating leverage for the next couple of quarters as we make those investments, but it's a good clean start in that guidance for the first quarter.
當然。我又是 Brian。第四季我提到 Nurse and Allied(護理與輔助醫療)部門有一項精算利益(actuarial benefit),但我們也有一些其他準備金(reserve)增加,所以合計起來影響相當有限。因此從 SG&A 的角度看,第四季相對乾淨。我們給出的第一季指引也沒有任何不尋常之處。所以我認為這是今年一個合理的起點。隨著時間推進,我們預期能產生槓桿效益(leverage)。但短期內我們也——即使可以產生更多槓桿,我們同時也在投資業務並投入這些計畫。因此在接下來幾個季度,當我們進行這些投資時,你可能不會看到那麼多的營運槓桿。不過第一季的指引是一個良好且乾淨的起點。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
Okay. And then, this is my last question on the MSP, [Tom]. And I think I jotted down, you said about 45% of revenues were coming from MSP-related contracts. I don't know if that's overall or that's a specific subsegment. But I guess, that grows as you get more MSP contracts, as you get a better fill rate on the MSPs you have, can you just maybe give us a little bit more flavor as to what are the -- what is contributing to that becoming a higher and higher percentage at this point? How much of it is just new MSPs and how much is better fill rates or something else that maybe I'm not thinking of?
好的。最後一題是關於 MSP,[Tom]。我記下來你說大約 45% 的營收來自 MSP 相關合約。我不確定這是整體還是某個特定子部門。不過我想,隨著你們拿到更多 MSP 合約、以及在既有 MSP 上提高填補率(fill rate),這個比例就會成長。你能否再多給我們一些脈絡,說明是什麼因素讓它在目前變成越來越高的占比?其中有多少只是新增 MSP,有多少是更好的填補率,或是其他我可能沒想到的因素?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Sure. So the 45% we were referring to was actually specifically for Allied. And so our Nursing is higher and Locums is lower. If you look at AMN's overall revenue, consolidated revenue, MSP revenue now constitutes 40% of that revenue. And it's coming from both increased fill rates but also increasing our gross spend under management and it goes back to the wins that we've had over the last year.
當然。所以我們提到的 45% 其實是特別針對 Allied(輔助醫療)。因此我們的 Nursing(護理)更高,而 Locums(代班醫師)更低。如果看 AMN 的整體營收、合併營收,MSP 營收現在占其中的 40%。這來自於填補率提升,也來自於我們管理下的總支出(gross spend under management)增加,而這又回到我們在過去一年所取得的贏單(wins)。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
Okay. Do you have any sense what that 40% would have been maybe a year ago or something, roughly?
好的。你大概知道那個 40% 可能在一年前左右大概會是多少嗎?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
It was around 35%. And the year before, probably close to 32%, 33%. Of course, 10 years ago, it was nothing. And so this is -- as you well know, A.J., this is extremely positive for AMN's business model and our ability to not only execute well and serve our clients better but also it does provide cushion and a mitigation in times when orders may be softer. And so we see it as a great way to create a healthier, stronger profile for the organization which it's done. And the more we can increase that, not only we are better partner for our clients, and we can pull through other service lines, which we've done, but we can also protect ourselves during any future periods.
大約是 35%。再前一年,可能接近 32%、33%。當然,10 年前幾乎是零。所以這——如你所知,A.J.——對 AMN 的商業模式以及我們不僅能夠良好執行、為客戶提供更好服務的能力而言,都是極為正面的;同時,在訂單可能較疲弱的時期,它也確實提供了緩衝與風險緩解。因此我們把它視為打造更健康、更強韌的組織輪廓的一個很好的方式,而它也確實做到了。而且我們越能提高這個比例,我們不僅能成為客戶更好的合作夥伴,也能帶動其他服務線的導入——我們也已經這麼做了——同時也能在未來任何期間保護自己。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
And just the last question on that. Is the gross spend, do you have any sense of maybe say your MSP contract -- clients, how much of that might be up year-to-year across the board?
就這點最後一個問題。關於總支出(gross spend),你是否大概知道,例如你們的 MSP 合約——客戶的支出,有多少可能在整體上年對年增加?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
So one way we look at it is our gross spend under management across our VMS and our MSP businesses, which is over $2 billion, I don't have that percentage right off the top of my head, we could probably get it for you before we hang up this call.
我們看的一種方式是:在我們的 VMS 與 MSP 業務之下、由我們管理的總支出(gross spend under management),超過 20 億美元。我現在一時沒有那個百分比的數字,但我們大概可以在這通電話結束前提供給你。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
Yes. Just was thinking about -- yours is going up because you're capturing more MSPs too and a variety of things, but I just wondered, sort of a proxy for the underlying growth for the sector maybe. Your best clients, how much are they spending this year versus last year would be an interesting dynamic. But yes, okay. That's good. All right.
是的。我在想——你們的數字上升是因為你們也在承接更多 MSP,以及各種因素,但我只是想知道,作為該產業底層成長的一個替代指標。你們最好的客戶今年相較去年花了多少,會是一個有趣的動態。不過好,了解。這樣就好。好。
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Again, this is Brian. I think the total spend on (inaudible) I think is up north of 20% year-over-year. But that -- keep in mind, that also -- that includes both the growth maybe within existing accounts but also new wins that have been rolled into that number as well.
再補充一下,我是 Brian。我認為(聽不清)上的總支出年對年增幅應該超過 20%。但——請記住,這也——同時包含既有帳戶內的成長,以及新贏得的案子也被納入那個數字。
Albert J. William Rice - Research Analyst
Albert J. William Rice - Research Analyst
Right. Yes. No, I was thinking about is there any way to get the -- a sort of a proxy for industry growth by looking at sort of gross spend on an apples-to-apples basis, but okay. No, that's good.
對。是的。不,我在想的是,有沒有辦法用同口徑(apples-to-apples)的總支出來看,作為產業成長的一個替代指標,但好吧。沒關係,這樣就好。
Operator
Operator
And we do have a question from Jason Plagman with Jefferies.
我們接到 Jefferies 的 Jason Plagman 的提問。
Jason Michael Plagman - Equity Associate
Jason Michael Plagman - Equity Associate
So on the MSP topic, the last 3 years now, you've been in the $200 million in total MSP wins per year or north of that. Is that -- should we expect that to continue for the next few years? Is that a typical win rate you're expecting?
關於 MSP 的話題,過去 3 年你們每年 MSP 新增得標總額都在 2 億美元左右或更高。這——我們是否應該預期未來幾年也會延續?這是你們預期的典型得標率嗎?
Dan White - President of Strategic Workforce Solutions
Dan White - President of Strategic Workforce Solutions
Jason, this is Dan. And I'll just give you a little bit more color. So 3 years ago, it wasn't nearly that high. Last year, we had roughly $185 million. And this year, it was 25% improvement on that. So the trend, I think, is more what you want to look at. I think that, clearly, this is a challenging market. But one of the things that really kind of warms my heart at this point is the recent movement towards seeing Locums. So again, color for last year, Susan mentioned the 230, about 10% of that was Locums. With really strong competitor pushing against that in terms of headwinds, we can already see at least half as much of that in our Q1 pipeline that's in contracting already. So we're seeing a lot of movement in Locums and consistent new buyer, new MSP buyer activity, so there's nothing in -- from my point of view that makes me feel like it's going to slow down at all.
Jason,我是 Dan。我再補充一些背景。3 年前其實沒有那麼高。去年我們大約是 1.85 億美元。今年則比去年提升了 25%。所以我認為你更該看的其實是這個趨勢。很明顯,這是一個具挑戰性的市場。但此刻真正讓我感到振奮的一點,是近期在 Locums(代班醫師)方面的動能。再補充一下去年的情況,Susan 提到的 2.3 億裡,大約 10% 是 Locums。在競爭對手帶來強烈逆風的情況下,我們已經在第一季的管線中看到至少一半那樣的量,而且已經在簽約中。因此我們看到 Locums 有很多動能,同時也持續有新的買方、新的 MSP 買方活動;所以就我看來,沒有任何跡象讓我覺得它會放緩。
Jason Michael Plagman - Equity Associate
Jason Michael Plagman - Equity Associate
That's helpful. And just on the travel nursing outlook, very strong for Q1. What are kind of some of the moving parts that you're thinking about as we get later into the year that would allow you to either maintain that or stay in that neighborhood?
這很有幫助。再問一下旅遊護理(travel nursing)的展望,第一季非常強勁。隨著進入年內後段,你們在思考哪些變動因素,能讓你們維持這樣的表現或至少維持在相近水準?
Ralph S. Henderson - President of Professional Services and Staffing
Ralph S. Henderson - President of Professional Services and Staffing
This is Ralph. Brian probably has a good sense on the seasonal trends but I'll start out. We do pull back a little bit in Q2. Do a lot of winter needs in California, Arizona, Florida that -- knowing those assignments come to an end, and we redeploy a majority of them into other places but it does -- volume does prop up just a little bit then. I think the reason we felt good about the rest of the year is, when you were just talking with Dan about, is the wins on the new MSP and we've had such great success in accelerating the implementation of those programs, it used to sometimes take us 120 days, it seems like we're down now below 90 days on average in getting them up and running. And so we had kind of ran a Six Sigma project that accelerated the pace of getting them up and running. So that's been good. And even just the kind and type and size of those deals, the geographic distribution, that all makes us feel good about it. I guess, probably, the last kind of anecdotal piece is in our conversations with health care administration, we're not hearing as much pressure on utilization of temporary help as we did last year at the beginning of the year. It's quite a bit less. I think they're less concerned about reimbursement and more concerned about capturing volumes, patient safety than they were last year.
我是 Ralph。Brian 可能對季節性趨勢更有概念,但我先說。我們在第二季會稍微回落一些。加州、亞利桑那、佛羅里達有很多冬季需求——我們知道那些派遣任務會結束,我們會把其中大多數重新部署到其他地方,但那時——量會稍微被撐住一點。我認為我們對今年其餘時間感到樂觀的原因是——就像你剛才和 Dan 談到的——新 MSP 的得標,以及我們在加速這些專案導入方面取得很大成功;過去有時要 120 天,現在看起來平均已降到 90 天以下就能上線運作。因此我們做了一個 Six Sigma 專案,加快了上線速度,這很不錯。再加上這些交易的性質、類型與規模,以及地理分布,都讓我們對後續更有信心。我想最後一個比較軼事性的觀察是:我們與醫療機構管理層的對話中,聽到他們對臨時人力使用量的壓力,沒有像去年年初那麼大,少了很多。我認為他們對給付(reimbursement)的擔憂降低了,反而更關注量能承接與病人安全,相較去年是如此。
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Jason, the other thing I would do is kind of overlay the macro environment and other demographic trends that are playing in our favor. So we talk frequently about the number of health care job openings versus the number of hires, which if you look at December, continues to be at pretty much an all-time high ratio of 1.9 physicians for every hire made. That does not seem to be abating. In fact, if anything, I think from our clients' perspective, there is concern that, that could get worse because of the competition for great clinical labor or really any kind of workforce within health care. And then, you also layer in there that other separations, which are primarily retirements continue to be on the rise. This is one of the BLS statistics that, I think, many people overlook. But if you look at the number of separations, just in December alone, it was 53,000, which was up 29% over prior year. And this, again, the vast majority of that are retirements. For the whole year, it was up, I think, close to that as well. So I think it's something that's not going to get easier. It's going to get more challenging for our clients to both recruit and retain but then also deal with these aging demographics of their own workforce.
Jason,另外我會把總體環境與其他對我們有利的人口結構趨勢疊加來看。我們常談到醫療職缺數相對於聘用數的差距;如果你看 12 月,這個比率幾乎仍在歷史高位:每完成 1 次聘用,約有 1.9 個醫師職缺。這看起來沒有緩解。事實上,若有什麼變化,從客戶角度看,他們擔心情況可能更糟,因為大家都在競爭優秀的臨床人力,甚至是醫療體系內任何類型的勞動力。再者,你還要把離職(separations)因素納入,其中主要是退休,而且仍在上升。這是 BLS 的一項統計,我認為很多人忽略了。但如果你看僅 12 月的離職人數,就有 53,000 人,年增 29%。而且這裡面絕大多數是退休。全年來看,我記得增幅也差不多接近這個水準。所以我認為這不是會變容易的事情;對客戶而言,招募與留才會更具挑戰,同時還要面對其自身員工隊伍的人口老化。
Operator
Operator
And we have a question from Mitra Ramgopal with Sidoti & Company.
我們接到 Sidoti & Company 的 Mitra Ramgopal 的提問。
Lalishwar Mitra Ramgopal - Research Analyst
Lalishwar Mitra Ramgopal - Research Analyst
Yes, just following up on the MSP. First, I know you mentioned you have a great pipeline in terms of new MSPs, but I was just wondering in terms of the existing business. I know back in 4Q, regarding Premier, you were able to add on RPO, VMS, et cetera. How much opportunities you have among existing clients for layering on such additional services?
是的,延續 MSP 的問題。首先,我知道你們提到在新增 MSP 方面有很好的管線,但我想問的是既有業務方面。我記得在第四季,關於 Premier,你們能夠加上 RPO、VMS 等等。在既有客戶中,你們有多少機會再疊加這類額外服務?
Dan White - President of Strategic Workforce Solutions
Dan White - President of Strategic Workforce Solutions
So there's probably a number of ways I can talk about that. This is Dan, Mitra. Just on RPO question you have, we had a really nice win in Q4 that puts them up a little over $2 million worth of long-term programs that were signed that are really helping us move into 2018 with some strong enthusiasm. Another way to think about that cross-selling kind of activity is when I look at our top 20 strategic accounts, and I look at -- we have 15 distinct offerings that we can sell into those customers, 75% use more than 5 of those offerings, which is up from 45% a year ago. So tremendous effort not only from the teams to introduce those but also to our customers looking at the whole, what I'd like to call, the entire human capital equation. One last nice bit of news is when you look at Avantas, which is our workforce optimization business, we're actually pushing and pulling the cross-selling. So in Q4, their revenue was up. And for all of '17, 40% of their new client revenue came from MSP clients. In addition, 2 of the larger wins in the second half of the year were existing Avantas clients. And so we're sort of getting the best of both worlds out of that particular customer base.
我可以從幾個角度來談。Mitra,我是 Dan。先就你問的 RPO 而言,我們在第四季有一個很不錯的得標,使長期專案簽約金額略高於 200 萬美元,這確實讓我們帶著很強的動能進入 2018。另一個思考這類交叉銷售活動的方式是:當我看我們前 20 大策略性客戶時——我們有 15 項不同的產品/服務可以銷售給這些客戶,其中 75% 使用超過 5 項服務,較一年前的 45% 明顯提升。這是團隊在導入上的巨大努力,同時也反映客戶在看待我所稱的「整體人力資本方程式」時的思維轉變。最後一個好消息是,當你看 Avantas(我們的勞動力最佳化業務)時,我們其實在推拉之間促成交叉銷售。因此在第四季,他們的營收成長;而在 2017 全年,他們新增客戶營收的 40% 來自 MSP 客戶。此外,下半年兩個較大的得標案是既有 Avantas 客戶。因此在這個特定客戶基礎上,我們算是兩邊的好處都拿到了。
Lalishwar Mitra Ramgopal - Research Analyst
Lalishwar Mitra Ramgopal - Research Analyst
That's great. And on the new MSPs, are you also selling more initial services?
太好了。那麼在新的 MSP 方面,你們也有銷售更多的初始服務嗎?
Dan White - President of Strategic Workforce Solutions
Dan White - President of Strategic Workforce Solutions
When you say more initial services, you mean more...
你說更多的初始服務,是指更多的……?
Lalishwar Mitra Ramgopal - Research Analyst
Lalishwar Mitra Ramgopal - Research Analyst
Yes, you already bundling in RPO, VMS, et cetera?
是的,你們已經把 RPO、VMS 等等打包在內了嗎?
Dan White - President of Strategic Workforce Solutions
Dan White - President of Strategic Workforce Solutions
No. Typically, we have Nurse and Allied that come together. More often, we're seeing Locums being considered at the same time. But typically, those things that would fall into Other Workforce Solutions would be considered add-on sales. And again, just to give you a sense, last year, we had 17 of those -- 17 million, excuse me, of those kinds of add-on service lines go through to our existing base.
沒有。通常我們是護理(Nurse)與醫療輔助(Allied)一起導入。更常見的是,我們看到臨時醫師(Locums)也會同時被納入考量。但一般而言,那些會歸類在其他人力解決方案(Other Workforce Solutions)之下的項目,會被視為加購式銷售。再給你一個概念,去年我們有 17——抱歉,是 1,700 萬美元——這類加購服務線,透過我們既有客戶基礎成交。
Operator
Operator
And we have a question from Bill Sutherland with the Benchmark Company.
我們有一個問題,來自 Benchmark Company 的 Bill Sutherland。
William Sutherland - Equity Analyst
William Sutherland - Equity Analyst
I think I've got one left. The perm trend, talk to me a little bit about kind of what the dynamics are for that improving and when you do think it's possible to -- what are kind of the issues to getting to positive comps again?
我想我只剩一個問題。關於永久職(perm)的趨勢,能否談談改善的動態是什麼?以及你認為要回到再次出現正向可比(positive comps)的可能性——主要障礙是什麼?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Sure, Bill. So I'm going to talk primarily about physician perm placement because that's where we've seen the greatest impact over the last couple of quarters. And as we've said, it is improving going into the first quarter but still under prior year a bit. And so the things that we're seeing improve are new searches. Everything starts with the searches and you have to be bringing in new searches in order to have the opportunity to make the placement, obviously. We did have a very difficult comp into -- in the second half of 2017 because we had the largest client for MHA reduce its number of searches because we filled them. It was a great new story, quite honesty, and we filled them but there was not an ongoing tail of recurring business there to backfill it and we had difficulty replacing those searches with enough new clients. The team, however, has really done a great job of reorganizing and re-approaching the market to look for more of those larger opportunities. And I have to say, to give credit, our academic and physician executive search teams in particular have had phenomenal growth over the last year. So we have to find more of these larger system clients in order to really have the more sustainable searches at this size of business. The other thing that occurred is our placements per recruiter dropped in the second half of last year and we're starting to see that improve. And that's obviously an important metric not only for us but for our clients to make sure that we're getting those jobs filled very quickly. So those things are improving. It's going to take a couple of quarters. I've mentioned before that we are reorganizing some of our teams a bit and also just generally making sure that we're doing the best job possible in recruiting and onboarding our new team members. And so we completely revamped our onboarding and training programs for our recruitment and marketing teams. So we're hopeful that we will begin to see the benefits of that as those individuals start to actually move into their roles and become productive. So I hope that, that's helpful.
當然可以,Bill。我主要會談醫師永久職安置(physician perm placement),因為過去幾個季度我們在這一塊受到的影響最大。正如我們所說,進入第一季時確實在改善,但仍略低於去年同期。我們看到改善的部分是新增搜尋案(new searches)。一切都從搜尋案開始;你必須帶進新的搜尋案,才有機會完成安置,這點很明顯。2017 年下半年我們面臨非常困難的可比基期,因為 MHA 最大的客戶在我們把職缺補齊後,降低了搜尋案數量。老實說,那是一個很好的成功案例,我們確實補齊了,但後續沒有持續性的循環業務尾端來補上,我們也很難用足夠的新客戶來替代那些搜尋案。不過,團隊確實做得很好,重新組織並重新切入市場,去尋找更多這類較大型的機會。我也必須給予肯定,尤其是我們的學術(academic)與醫師高階主管搜尋(physician executive search)團隊,在過去一年成長非常亮眼。因此,我們必須找到更多大型系統型客戶,才能在這個規模的業務上,擁有更可持續的搜尋案。另一件發生的事是,我們每位招募人員的安置數(placements per recruiter)在去年下半年下滑,而我們開始看到這項指標改善。這顯然是對我們以及對客戶都很重要的指標,確保我們能非常快速地把職缺補上。所以這些都在改善中。這需要幾個季度的時間。我之前也提過,我們正在對部分團隊做一些重整,同時也更全面地確保我們在招募與新進人員到職(onboarding)方面做到最好。因此,我們徹底翻新了招募與行銷團隊的到職與訓練計畫。我們希望,當這些人員真正進入角色並開始產出時,我們會開始看到成效。我希望這些說明有幫助。
William Sutherland - Equity Analyst
William Sutherland - Equity Analyst
No, that's very helpful. So the placements per recruiter last year coming down a bit, was that just kind of the general tone of the market as far as longer decision-making? Just longer cycle times with the clients? Was that the issue?
不,這非常有幫助。所以去年每位招募人員的安置數下滑一些,是不是因為市場整體氛圍導致決策時間拉長?客戶端的週期時間變長?問題在這裡嗎?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
No, I don't really think so, Bill. We really believe it was more on us, to be honest. We were getting the demand where we had good coverage out in the market. We also were short-staffed in terms of our marketers, which are the client sales-facing individuals with the market. So we weren't getting enough searches, but more than that, we weren't necessarily executing well on our placements. We weren't getting the candidates to clients to be interviewed even for the searches that we had. But again, that tide is turning and we're starting to see some better metrics so we feel better, but it's going to take a couple of quarters for us to get to a positive year-over-year position.
不,我不太這麼認為,Bill。老實說,我們真的認為更多是我們自身的原因。我們在市場上覆蓋良好的區域確實有取得需求。我們在行銷人員(marketers)方面也人手不足——他們是面向客戶、負責市場銷售的角色。因此我們沒有拿到足夠的搜尋案;但更重要的是,我們在安置執行上不一定做得好。即便是我們已有的搜尋案,我們也沒有把候選人送到客戶那邊進行面試。但同樣地,情勢正在轉變,我們開始看到一些更好的指標,所以我們感覺更好一些;不過要回到年對年(year-over-year)正成長的位置,仍需要幾個季度。
William Sutherland - Equity Analyst
William Sutherland - Equity Analyst
Okay. And then, one just stepping back question. So you're looking at a trend line for Nurse and Allied that, on a year-over-year basis, seems it could be sustainable, maybe not quite as good as Q1. You've got, definitely, a better trend outlook for Locum and also for OWS in the latter part of the year. Is that kind of how we should think about the whole year?
好的。然後再退一步問一個問題。你們看到護理與醫療輔助(Nurse and Allied)的趨勢線,在年對年基礎上看起來可能是可持續的,也許沒有第一季那麼好。你們對臨時醫師(Locum)以及 OWS 在今年後段也有明顯更好的趨勢展望。這就是我們看待全年表現的方式嗎?
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Yes, I think that's a good way to encapsulate it.
是的,我認為這樣概括是很好的。
Operator
Operator
And we have a question from Brooks O'Neil with Lake Street Capital Markets.
我們有一個問題,來自 Lake Street Capital Markets 的 Brooks O'Neil。
Brooks Gregory O'Neil - Senior Research Analyst
Brooks Gregory O'Neil - Senior Research Analyst
I get to ask maybe the last question and perhaps the most important one from an investor perspective. I saw some things that suggest that people think you missed the consensus adjusted EPS estimate. I think, Brian, I heard you say that was probably entirely related to a different tax rate than you assumed. Could you just help us to be sure we understand what's going on there, that 39% to 42% rate you talked about?
我可能可以問最後一個問題,也許從投資人角度來看是最重要的一個。我看到一些說法暗示大家認為你們沒有達到市場一致預期(consensus)的調整後 EPS 估計。我想,Brian,我聽到你說那可能完全是因為你們實際稅率與原先假設不同。你能否幫我們確認一下到底發生了什麼,關於你提到的 39% 到 42% 的稅率?
Brian M. Scott - CAO, CFO & Treasurer
Brian M. Scott - CAO, CFO & Treasurer
Sure, Brooks. So my understanding is that consensus was $0.63, which is what we came in at. And we pointed out the tax rate impact and partly because we have obviously been on the top line and so in line consensus, wanted to make sure that we addressed that, that was driven 100% by that tax rate being a bit higher than what we've seen in the consensus, which was, I think, the consensus was around 40%. We came in at 42%. There were a couple of different things that hit in the quarter just kind of year-end true-ups on some state rates and no one big item but just a few things that ended up being a bit larger. So the rate in the quarter was above what we had guided for Q4 and above what had been modeled in consensus. And really, every 1% higher is about $0.01, so the guidance we've given of 39% versus what we came in at 42%, that's a $0.03 impact. So adding that back, it would have been a $0.66 adjusted EPS.
當然可以,Brooks。我的理解是,一致預期是 0.63 美元,而我們實際也是 0.63。我們也指出了稅率的影響,部分原因是我們在營收端(top line)表現良好、也符合一致預期,因此希望確保我們有把這點說清楚:這 100% 是因為稅率比一致預期所反映的略高;我想一致預期大約是 40%,而我們是 42%。本季有幾個不同因素影響,主要是年底對某些州稅率做的調整(true-ups);沒有單一重大項目,只是幾個因素加總後略大一些。因此,本季稅率高於我們對第四季的指引,也高於一致預期模型所假設的水準。基本上,稅率每高 1%,約影響 0.01 美元;所以我們給的 39% 指引相較於實際 42%,就是 0.03 美元的影響。把這個加回去,調整後 EPS 會是 0.66 美元。
Brooks Gregory O'Neil - Senior Research Analyst
Brooks Gregory O'Neil - Senior Research Analyst
Great. That's what I was thinking. And then, just lastly, I seem to recall that you were having some issues in the hospitalist business and I haven't heard you say much about that business on the call. So I was hoping to just get an update on what's happening there now?
很好,這正是我在想的。最後一個問題,我記得你們在住院醫師(hospitalist)業務上遇到一些問題,但我在這通電話裡沒有聽到你們談很多。我想請你們更新一下目前那邊的情況?
Ralph S. Henderson - President of Professional Services and Staffing
Ralph S. Henderson - President of Professional Services and Staffing
Yes, this is Ralph. Hospitalist did improve sequentially in the quarter but they're still below prior year. And we had some recent wins lately in that space because of some new customers coming on and that's helpful. But it's still a bit of a drag. And we're seeing a shift. Facilities going to advance practice specialties, physician assistants, nurse petitioners in those roles, which have been good for that side of the business, but that's had a lower bill rate, unfortunately, than the hospitalists. So not -- we're not out of the woods yet, I guess, on this one. But certainly, a little less dependent on it. It's about 22% or so of our Locums business, so if it's starting to improve, we'll let you know right away.
是的,我是 Ralph。住院醫師業務在本季較上一季有所改善,但仍低於去年同期。最近我們在那個領域也有一些新案子勝出,因為有一些新客戶導入,這是有幫助的。但它仍然有點拖累。我們也看到一個轉變:醫療機構轉向進階執業專科(advance practice specialties),由醫師助理(physician assistants)、執業護理師(nurse practitioners)擔任那些角色,這對那一側的業務是有利的,但不幸的是,這些角色的計費率(bill rate)比住院醫師低。所以我想我們還不能說已經完全走出困境。不過,確實對它的依賴程度稍微降低了。它大約占我們臨時醫師(Locums)業務的 22% 左右,所以如果它開始改善,我們會立刻告訴你們。
Operator
Operator
And we have no additional questions in the queue. I'll turn it back to our speakers.
目前提問隊列中沒有其他問題。我把時間交回給我們的講者。
Susan R. Salka - President, CEO & Director
Susan R. Salka - President, CEO & Director
Wonderful. Well, we like to thank everyone for joining us today on the call and certainly for your ongoing support. We're very much looking forward to updating you on our next quarterly earnings call.
太好了。我們要感謝各位今天參與電話會議,也感謝各位持續的支持。我們非常期待在下一次季度財報電話會議上向各位更新。
Operator
Operator
Thank you. And ladies and gentlemen, this will conclude the teleconference for today. Thank you for your participation and for using AT&T Executive TeleConference service. You may now disconnect.
謝謝。各位女士、先生,今天的電話會議到此結束。感謝各位的參與,以及使用 AT&T Executive TeleConference 服務。您現在可以掛線。